Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 273

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 273
---
 On August 27, 2024, Parent, MultiplAI and the MultiplAI Shareholders (with APx’s consent) terminated the MultiplAI Share Purchase Agreement. As a result of such termination, OmnigenicsAI will not acquire MultiplAI, their business will not be combined pursuant to the Business Combination Agreement, and all rights and obligations of MultiplAI under the Business Combination Agreement ceased and terminated, subject to certain exceptions. For more information on the decision to terminate the MultiplAI Share Purchase Agreement, see “ — Decision to Terminate the MultiplAI Share Purchase Agreement.” Except as set forth above, no other terms of the Business Combination have been modified, and OmnigenicsAI and APx intend to complete the combination of our businesses (without the acquisition of MultiplAI) as set forth in the Business Combination Agreement. APx Board of Directors’ Reasons for the Approval of the Business Combination As described above, the APx Board, in evaluating the Business Combination, consulted with APx’s management and advisors. In reaching its unanimous decision to approve the Business Combination Agreement and the transactions contemplated by the Business Combination Agreement, the APx Board considered a range of factors, including, but not limited to, the factors discussed below. In light of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the APx Board did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it considered in reaching its determination and supporting its decision. The APx Board viewed its decision as being based on the information available and the factors presented to and considered by it. In addition, individual directors may have given different weight to different factors. This explanation of APx’s reasons for the Business Combination and all other information presented in this section is forward -lookingin nature and, therefore, should be read together with the factors discussed under the section titled “ Cautionary Note Regarding Forward -Looking Statements.” 127

In connection with analyzing the Business Combination, APx’s management reviewed and compared, using publicly available information, certain financial information for the Company corresponding to financial information, ratios and public market multiples for certain companies believed by APx’s management and its advisors, based on their experience and judgment, to be comparable to the Company. None of such companies is identical to the Company. Before reaching its decision, the APx Board reviewed the results of the due diligence conducted by its management, members of the Sponsor and APx’s advisors